|
MechanismCOX-2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hangzhou Iressa Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Iressa Biomedical Technology Co., Ltd.
100 Deals associated with Hangzhou Iressa Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Hangzhou Iressa Biomedical Technology Co., Ltd.